Abstract
The Model for End-stage Liver Disease (MELD) score predicts mortality after transjugular intrahepatic portosystemic shunt (TIPS) creation. MELD components include two liver lab variables (bilirubin and INR) and one kidney lab variable (creatinine). Though higher MELD scores are known to confer higher 3-month mortality, it has been suggested that variation in underlying MELD driving lab values— “liver driven” vs. “kidney driven” values—translate into differential risk to patients with the same MELD score.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
